ArticleDrug design, development and therapy2025

Astragaloside IV Alleviates Systemic Lupus Erythematosus by Modulating ITGB1/PTK2/p38 Pathway: Integrated Network Pharmacology and Experimental Validation.

Zhongfu Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.